Cohen E, Hafner R, Rotenberg Z, Fadilla M, Garty M
Internal Medicine F Department, Rabin Medical Center, Beilinson Campus, Petach-Tikva, Israel.
Eur J Clin Pharmacol. 1998 Aug;54(6):455-8. doi: 10.1007/s002280050492.
To compare the efficacy and adverse effects of ketorolac and diclofenac in the treatment of renal colic.
In a double-blind, randomized clinical trial, 57 patients admitted to the emergency room for renal colic, received either 30 mg of ketorolac or 75 mg of diclofenac i.m. (intramuscularly). Evaluations were performed at 1, 2 h and 6 h after treatment. Pain was assessed by a four-point verbal rating scale (VRS) and a visual analogue scale (VAS). Only patients with at least moderate pain according to the VRS were included. Seventy-five milligrams of pethidine i.m. was given as rescue medicine, if insufficient analgesia was achieved. The adverse effects recorded were sedation, nausea and vomiting.
There was no significant difference between ketorolac and diclofenac, with respect to pain level over time, the number of patients requiring rescue medicine, or the level of adverse effects.
Ketorolac and diclofenac are equally effective in the treatment of renal colic.
比较酮咯酸和双氯芬酸治疗肾绞痛的疗效及不良反应。
在一项双盲随机临床试验中,57名因肾绞痛入住急诊室的患者,分别接受30毫克酮咯酸或75毫克双氯芬酸肌肉注射治疗。在治疗后1小时、2小时和6小时进行评估。采用四点口述分级量表(VRS)和视觉模拟量表(VAS)评估疼痛程度。仅纳入根据VRS至少为中度疼痛的患者。若镇痛效果不佳,给予75毫克哌替啶肌肉注射作为急救药物。记录的不良反应包括镇静、恶心和呕吐。
酮咯酸和双氯芬酸在疼痛程度随时间的变化、需要急救药物的患者数量或不良反应程度方面无显著差异。
酮咯酸和双氯芬酸在治疗肾绞痛方面同样有效。